Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population

E. Ciruelos, G. Jerusalem, M. Martin, V. C.G. Tjan-Heijnen, P. Neven, J. Gavila, F. Montemurro, D. Generali, I. Lang, M. J. Martínez-Serrano, M. F. Perelló, P. Conte

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population'. Together they form a unique fingerprint.

Medicine & Life Sciences